Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
J. Andrew Bird, A. Wesley Burks(University of North Carolina at Chapel Hill), Julie Wang(Shanghai Jiao Tong University), Andrew J. MacGinnitie(Boston Children's Hospital), Amal Assa’ad(Cincinnati Children's Hospital Medical Center), Jonathan M. Spergel(University of Pennsylvania), Brian P. Vickery(Emory University), Susan Laubach(University of California San Diego), Jennifer Heimall(Children's Hospital of Philadelphia), Benjamin P. Davis(University of Iowa Hospitals and Clinics), Edwin Kim(University of North Carolina at Chapel Hill), Rima Rachid(Boston Children's Hospital), Stacie M. Jones(Arkansas Children's Hospital), Antonella Cianferoni(Children's Hospital of Philadelphia), Stephanie A. Leonard(University of California San Diego), Elena Crestani(Boston Children's Hospital)
The Journal of Allergy and Clinical Immunology In Practice
October 31, 2017
Cited by 200
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k